MedPAC Wants To Boost Generic Use By Low-Income Part D Enrollees Via Lower Copays

At its December meeting, the Medicare Payment Advisory Commission recommends that Congress increase the difference between copayments for generic and branded drugs used by low-income beneficiaries to encourage greater generic use in that population.